These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 36996971)

  • 1. Alzheimer's disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs.
    Monteiro AR; Barbosa DJ; Remião F; Silva R
    Biochem Pharmacol; 2023 May; 211():115522. PubMed ID: 36996971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.
    Kashif M; Sivaprakasam P; Vijendra P; Waseem M; Pandurangan AK
    Curr Pharm Des; 2023; 29(43):3428-3441. PubMed ID: 38038007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of tau protein in Alzheimer's disease: The prime pathological player.
    Muralidar S; Ambi SV; Sekaran S; Thirumalai D; Palaniappan B
    Int J Biol Macromol; 2020 Nov; 163():1599-1617. PubMed ID: 32784025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood Biomarkers in Alzheimer's Disease.
    Mandal PK; Maroon JC; Garg A; Arora NK; Bansal R; Kaushik A; Samkaria A; Kumaran G; Arora Y
    ACS Chem Neurosci; 2023 Nov; 14(22):3975-3978. PubMed ID: 37878665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease.
    Jazvinšćak Jembrek M; Slade N; Hof PR; Šimić G
    Prog Neurobiol; 2018 Sep; 168():104-127. PubMed ID: 29733887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease.
    Bhatia V; Sharma S
    J Neurol Sci; 2021 Feb; 421():117253. PubMed ID: 33476985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-β, tau, and the cholinergic system in Alzheimer's disease: seeking direction in a tangle of clues.
    Majdi A; Sadigh-Eteghad S; Rahigh Aghsan S; Farajdokht F; Vatandoust SM; Namvaran A; Mahmoudi J
    Rev Neurosci; 2020 May; 31(4):391-413. PubMed ID: 32017704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the development of new drugs in Alzheimer's disease.
    Piau A; Nourhashémi F; Hein C; Caillaud C; Vellas B
    J Nutr Health Aging; 2011 Jan; 15(1):45-57. PubMed ID: 21267520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.
    Liu Z; Li T; Li P; Wei N; Zhao Z; Liang H; Ji X; Chen W; Xue M; Wei J
    Oxid Med Cell Longev; 2015; 2015():352723. PubMed ID: 26171115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Chronological Review of Potential Disease-Modifying Therapeutic Strategies for Alzheimer's Disease.
    Ettcheto M; Busquets O; Espinosa-Jiménez T; Verdaguer E; Auladell C; Camins A
    Curr Pharm Des; 2020; 26(12):1286-1299. PubMed ID: 32066356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing Aβ load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease.
    Kalra J; Khan A
    Eur J Pharmacol; 2015 Oct; 764():571-581. PubMed ID: 26209363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A three-dimensional human neural cell culture model of Alzheimer's disease.
    Choi SH; Kim YH; Hebisch M; Sliwinski C; Lee S; D'Avanzo C; Chen H; Hooli B; Asselin C; Muffat J; Klee JB; Zhang C; Wainger BJ; Peitz M; Kovacs DM; Woolf CJ; Wagner SL; Tanzi RE; Kim DY
    Nature; 2014 Nov; 515(7526):274-8. PubMed ID: 25307057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Vitamin E in the Treatment of Alzheimer's Disease: Evidence from Animal Models.
    Gugliandolo A; Bramanti P; Mazzon E
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal ions influx is a double edged sword for the pathogenesis of Alzheimer's disease.
    Wang P; Wang ZY
    Ageing Res Rev; 2017 May; 35():265-290. PubMed ID: 27829171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies.
    Kaur D; Behl T; Sehgal A; Singh S; Sharma N; Bungau S
    Neurochem Res; 2021 Nov; 46(11):2832-2851. PubMed ID: 34357520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harnessing the Therapeutic Potential of Peptides for Synergistic Treatment of Alzheimer's Disease by Targeting Aβ Aggregation, Metal-Mediated Aβ Aggregation, Cholinesterase, Tau Degradation, and Oxidative Stress.
    Singh K; Kaur A; Goyal B; Goyal D
    ACS Chem Neurosci; 2024 Jul; 15(14):2545-2564. PubMed ID: 38979773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigations on oxidative stress and therapeutical implications in dementia.
    Durany N; Münch G; Michel T; Riederer P
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 3():68-73. PubMed ID: 10654103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies.
    Chen Y; Fu AKY; Ip NY
    Pharmacol Ther; 2019 Mar; 195():186-198. PubMed ID: 30439458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease: Recent treatment strategies.
    Vaz M; Silvestre S
    Eur J Pharmacol; 2020 Nov; 887():173554. PubMed ID: 32941929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.